← Leaderboards
Kevin M Gray
Medical University Of South Carolina
$28,834,568
Attributed
$43,592,163
Total exposure
13
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $6M · FY2007–25$10M$7.5M$5M$2.5M$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$46,579,437 · 14
By mechanism
R01$13,404,992 · 6
U01$12,874,148 · 2
K12$11,798,503 · 2
U54$3,888,117 · 2
UH3$2,936,766 · 1
UG3$1,676,911 · 1
Top collaborators
- Lindsay Squeglia16 shared
- Aimee L Mcrae-Clark15 shared
- Sudie E Back7 shared
- Elizabeth J Santa Ana6 shared
- Brett Froeliger5 shared
- Peter W Kalivas5 shared
Most similar at Medical University Of South Carolina
Same institution · by research overlap
- Lindsay Squeglia$10,315,385
- Erin A McClure$9,972,633
- Lisa M McTeague$3,489,113
- Carlos F Salinas$4,519,272
- Caroline Westwater$4,723,443
Others in their field
Top investigators on “Pharmaceutical Preparations”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- David Heimbrook · Leidos Biomedical Research, Inc.$266,816,120
- Leonard Freedman · Leidos Biomedical Research, Inc.$240,520,687
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$196,976,947
- Lawrence Corey · Fred Hutchinson Cancer Center$196,976,947
Research focus
Pharmaceutical PreparationsPlacebosResearch PersonnelDesignAbstinenceAdultPatient Self-ReportFollow-UpSubstance Use DisorderResponseParticipantAdolescentAdolescenceClinical ResearchPharmacotherapyAddictionMarijuana UseStandardizationScienceTrainingMonitorCannabisSafetyAlcohols
Grant awards (65)
13/21 ABCD-USA CONSORTIUM: RESEARCH PROJECT SITE AT MUSC$1,129,499
U01 · FY2025 · DA
AACAP Physician Scientist Program in Substance Use$985,620
K12 · FY2025 · DA · contact PI
Clinical Scientists Training Program in Addictions at MUSC$534,447
K12 · FY2025 · DA
Sex Differences in the Interface between Cannabis Use and Stress among Emerging Adults$298,716
U54 · FY2025 · DA · contact PI
MUSC Specialized Center of Research Excellence on Sex Differences Renewal 2022$1,495,542
U54 · FY2024 · DA
13/21 ABCD-USA CONSORTIUM: RESEARCH PROJECT SITE AT MUSC$1,139,709
U01 · FY2024 · DA
Clinical Scientists Training Program in Addictions at MUSC$534,447
K12 · FY2024 · DA
Sex Differences in the Interface between Cannabis Use and Stress among Emerging Adults$298,716
U54 · FY2024 · DA · contact PI
AACAP Physician Scientist Program in Substance Use$1,771,653
K12 · FY2023 · DA · contact PI
MUSC Specialized Center of Research Excellence on Sex Differences Renewal 2022$1,491,732
U54 · FY2023 · DA
13/21 ABCD-USA CONSORTIUM: RESEARCH PROJECT SITE AT MUSC$1,150,296
U01 · FY2023 · DA
Clinical Scientists Training Program in Addictions at MUSC$534,447
K12 · FY2023 · DA
Sex Differences in the Interface between Cannabis Use and Stress among Emerging Adults$303,411
U54 · FY2023 · DA · contact PI
AACAP Physician Scientist Program in Substance Use$1,771,769
K12 · FY2022 · DA · contact PI
13/21 ABCD-USA CONSORTIUM: RESEARCH PROJECT SITE AT MUSC$1,154,681
U01 · FY2022 · DA
A Proof-of-Concept Trial of N-Acetylcysteine for Adolescent Alcohol Use Disorder$629,534
R01 · FY2022 · AA · contact PI
Clinical Scientists Training in Addictions at MUSC$531,467
K12 · FY2022 · DA
AACAP Physician Scientist Program in Substance Use$1,389,449
K12 · FY2021 · DA · contact PI
13/21 ABCD-USA CONSORTIUM: RESEARCH PROJECT SITE AT MUSC$1,170,835
U01 · FY2021 · DA
Advancing Varenicline as a Treatment for Cannabis Use Disorder$981,666
UH3 · FY2021 · DA
A Proof-of-Concept Trial of N-Acetylcysteine for Adolescent Alcohol Use Disorder$724,982
R01 · FY2021 · AA · contact PI
Clinical Scientists Training in Addictions at MUSC$531,467
K12 · FY2021 · DA
N-Acetylcysteine and Contingency Management for Youth Cannabis Use Disorder$513,162
R01 · FY2021 · DA · contact PI
AACAP Physician Scientist Program in Substance Use$386,320
K12 · FY2021 · DA · contact PI
AACAP Physician Scientist Program in Substance Use$1,233,016
K12 · FY2020 · DA · contact PI
13/21 ABCD-USA CONSORTIUM: RESEARCH PROJECT SITE AT MUSC$1,186,732
U01 · FY2020 · DA
Advancing Varenicline as a Treatment for Cannabis Use Disorder$981,666
UH3 · FY2020 · DA
A Proof-of-Concept Trial of N-Acetylcysteine for Adolescent Alcohol Use Disorder$717,092
R01 · FY2020 · AA · contact PI
N-Acetylcysteine and Contingency Management for Youth Cannabis Use Disorder$648,269
R01 · FY2020 · DA · contact PI
A Randomized Controlled Trial of N-Acetylcysteine for Alcohol Use Disorder and Comorbid PTSD$602,982
R01 · FY2020 · AA
Clinical Scientists Training in Addictions at MUSC$531,467
K12 · FY2020 · DA
Randomized Controlled Trial of N-acetylcysteine for Alcohol Use Disorder and Comorbid PTSD$51,948
R01 · FY2020 · AA
Advancing Varenicline as a Treatment for Cannabis Use Disorder$973,434
UH3 · FY2019 · DA
13/13 ABCD-USA Consortium: Research Project$898,000
U01 · FY2019 · DA
A Proof-of-Concept Trial of N-Acetylcysteine for Adolescent Alcohol Use Disorder$712,341
R01 · FY2019 · AA · contact PI
A Randomized Controlled Trial of N-Acetylcysteine for Alcohol Use Disorder and Comorbid PTSD$676,468
R01 · FY2019 · AA
N-Acetylcysteine and Contingency Management for Youth Cannabis Use Disorder$648,269
R01 · FY2019 · DA · contact PI
Clinical Scientists Training in Addictions at MUSC$531,467
K12 · FY2019 · DA
Translational Neuropsychopharmacology Research of Nicotine Addiction$292,776
R01 · FY2019 · DA
13/13 ABCD-USA Consortium: Research Project$11,721
U01 · FY2019 · DA
13/13 ABCD-USA Consortium: Research Project$823,000
U01 · FY2018 · DA
A Proof-of-Concept Trial of N-Acetylcysteine for Adolescent Alcohol Use Disorder$672,852
R01 · FY2018 · AA · contact PI
N-Acetylcysteine and Contingency Management for Youth Cannabis Use Disorder$648,269
R01 · FY2018 · DA · contact PI
Translational Neuropsychopharmacology Research of Nicotine Addiction$607,118
R01 · FY2018 · DA
A Randomized Controlled Trial of N-Acetylcysteine for Alcohol Use Disorder and Comorbid PTSD$556,879
R01 · FY2018 · AA
Clinical Scientists Training in Addictions at MUSC$531,467
K12 · FY2018 · DA
A Randomized Controlled Trial of N-Acetylcysteine for Alcohol Use Disorder and Comorbid PTSD$95,783
R01 · FY2018 · AA
13/13 ABCD-USA Consortium: Research Project$11,721
U01 · FY2018 · DA
13/13 ABCD-USA Consortium: Research Project$902,224
U01 · FY2017 · DA
Advancing Varenicline as a Treatment for Cannabis Use Disorder$849,487
UG3 · FY2017 · DA
Translational Neuropsychopharmacology Research of Nicotine Addiction$611,155
R01 · FY2017 · DA
N-Acetylcysteine and Contingency Management for Youth Cannabis Use Disorder$609,648
R01 · FY2017 · DA · contact PI
A Randomized Controlled Trial of N-Acetylcysteine for Alcohol Use Disorder and Comorbid PTSD$556,879
R01 · FY2017 · AA
Advancing Varenicline as a Treatment for Cannabis Use Disorder$827,424
UG3 · FY2016 · DA
A Randomized Controlled Trial of Varenicline for Adolescent Smoking Cessation$697,074
U01 · FY2016 · DA · contact PI
Translational Neuropsychopharmacology Research of Nicotine Addiction$623,065
R01 · FY2016 · DA
A Randomized Controlled Trial of N-Acetylcysteine for Alcohol Use Disorder and Comorbid PTSD$573,025
R01 · FY2016 · AA
A Randomized Controlled Trial of Varenicline for Adolescent Smoking Cessation$659,666
U01 · FY2015 · DA · contact PI
Translational Neuropsychopharmacology Research of Nicotine Addiction$599,392
R01 · FY2015 · DA
A Randomized Controlled Trial of Varenicline for Adolescent Smoking Cessation$670,803
U01 · FY2014 · DA · contact PI
A Randomized Controlled Trial of Varenicline for Adolescent Smoking Cessation$643,971
U01 · FY2013 · DA · contact PI
A Randomized Controlled Trial of Varenicline for Adolescent Smoking Cessation$624,216
U01 · FY2012 · DA · contact PI
A Controlled Trial of N-Acetylcysteine (NAC) in Cannabis Dependent Adolescents$360,845
R01 · FY2010 · DA · contact PI
A Controlled Trial of N-Acetylcysteine (NAC) in Cannabis Dependent Adolescents$360,781
R01 · FY2009 · DA · contact PI
Combined Pharmaco/Behavior Therapy in Adolescent Smokers$311,478
R01 · FY2007 · DA · contact PI